P-1044. Interdisciplinary Initiative for Sustained CLABSI Reduction

Abstract Background Central line-associated bloodstream infections (CLABSIs) are correlated with elevated morbidity and mortality, with an estimated excess cost of more than $30,000 per event. Our 425-bed acute care hospital had a CLABSI incidence of 1.289/1,000 patient days with a standardized infection ratio (SIR) of 1.256, exceeding facility goals. Existing prevention strategies, including root cause analysis and a maintenance bundle had previously failed to impact facility-wide CLABSI rates. Methods Our facility initiated a collaborative CLABSI prevention quality improvement project, with dedicated ID physician and nursing champions. Areas of focus included device utilization rates, site selection, dressing maintenance, and antisepsis. The physician champion liaised with providers to establish criteria for removal and replacement of central lines in high-risk locations (femoral and internal jugular) and in CVLs placed emergently. The physician champion conducts daily audits of central line necessity in high acuity areas - critical care and oncology. In collaboration with unit leadership and bedside staff, the nurse champion conducts daily assessments of central line dressing and CHG barrier integrity. An alcoholic chlorhexidine device swab is used on all vascular access devices within high acuity areas and on each patient with a central venous catheter throughout the facility. Results The project resulted in a substantial and sustained reduction in CLABSI rates, from 1.289/1,000 device days in 2021 to 0.592 in 2024. Similarly, the NHSN standardized infection ratio (SIR) decreased from 1.256 to 0.571, a 54% reduction. Furthermore, CVL utilization decreased slightly, as represented a reduction in NHSN standardized utilization ratios (SURs) from 0.537 in 2021 to 0.484 in 2024. Conclusion By emphasizing interdisciplinary cooperation, real-time feedback, and enhanced device maintenance, our facility achieved and sustained a substantial reduction in CLABSIs. Intervention practices remain in place and our facility continues to examine processes to further integrate these practices into our culture. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.1239
Primary Topic
Central Venous Catheters and Hemodialysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1044. Interdisciplinary Initiative for Sustained CLABSI Reduction

Jessica Miller, James D. Newton, Sandra Williams, Julie Gregory et al.
Open Forum Infectious Diseases
Central Venous Catheters and Hemodialysis
article

P-1044. Interdisciplinary Initiative for Sustained CLABSI Reduction

Jessica Miller, James D. Newton, Sandra Williams, Julie Gregory, Bianca Johns, Margo Leavitt, Alex Woods
article en

Abstract

Abstract Background Central line-associated bloodstream infections (CLABSIs) are correlated with elevated morbidity and mortality, with an estimated excess cost of more than $30,000 per event. Our 425-bed acute care hospital had a CLABSI incidence of 1.289/1,000 patient days with a standardized infection ratio (SIR) of 1.256, exceeding facility goals. Existing prevention strategies, including root cause analysis and a maintenance bundle had previously failed to impact facility-wide CLABSI rates. Methods Our facility initiated a collaborative CLABSI prevention quality improvement project, with dedicated ID physician and nursing champions. Areas of focus included device utilization rates, site selection, dressing maintenance, and antisepsis. The physician champion liaised with providers to establish criteria for removal and replacement of central lines in high-risk locations (femoral and internal jugular) and in CVLs placed emergently. The physician champion conducts daily audits of central line necessity in high acuity areas - critical care and oncology. In collaboration with unit leadership and bedside staff, the nurse champion conducts daily assessments of central line dressing and CHG barrier integrity. An alcoholic chlorhexidine device swab is used on all vascular access devices within high acuity areas and on each patient with a central venous catheter throughout the facility. Results The project resulted in a substantial and sustained reduction in CLABSI rates, from 1.289/1,000 device days in 2021 to 0.592 in 2024. Similarly, the NHSN standardized infection ratio (SIR) decreased from 1.256 to 0.571, a 54% reduction. Furthermore, CVL utilization decreased slightly, as represented a reduction in NHSN standardized utilization ratios (SURs) from 0.537 in 2021 to 0.484 in 2024. Conclusion By emphasizing interdisciplinary cooperation, real-time feedback, and enhanced device maintenance, our facility achieved and sustained a substantial reduction in CLABSIs. Intervention practices remain in place and our facility continues to examine processes to further integrate these practices into our culture. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Washington Regional Medical Center (US)
Good health and well-being
Openalex Percentile: Top 92%
Central Venous Catheters and Hemodialysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.